Key facts
- Notable investors include BSV Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SeqVision
- ·The full record, as it builds
Funding rounds
No funding rounds for SeqVision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SeqVision
Provider of DNA sequencing services intended to provide fast and reliable sequencing results to meet the needs of researchers and laboratories. The company offers rapid turnaround DNA sequencing services with a focus on quality and customization, enabling customers to receive accurate results within one business day and tailored support for unique projects.
- Sector
- Healthcare
- HQ
- Vilnius, Lithuania
- Founded
- 2022
- Website
- seqvision.com/
- Ownership
- Privately Held (backing)
SeqVision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SeqVision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SeqVision in its N-PORT filings yet. We sweep new filings monthly.